ACINETOBACTER BAUMANNII RESISTANT TO ANTIMICROBIAL DRUGS FROM AN UNIVERSITY HOSPITAL AT CUIABÁ – MT
Abstract
Acinetobacter baumanii has recently taken special notice, and numerous are the reports of infection breakouts in hospital environments worldwide. The extensive use of antibacterial drugs in hospitals has contributed to the increase of muti-resistant strains of A. baumanii, including resistance to carbapenems, which makes the bacteria more difficult to eliminate. This study intends to analyze the susceptibility profiles of different strains of A. baumanii isolated
from clinical samples of patients in treatment in Hospital Universitário de Cuiabá – MT. It consists of a retrospective descriptive study. The bacteria were isolated in appropriate culture media. The identification and antimicrobial susceptibility testing were performed by biochemical tests and Kirby Bauer qualitative method, and Etest quantitative one. From 184 tested samples, 85.3% showed multidrug resistance, especially to cephalosporins (3rd and 4th generation), aminoglycosides and carbapenems. However, 100% of the strains were susceptible to polymyxin B. It was observed that the intensive care unit was the most affected by A. baumannii, and tracheal aspirate was the most prevalent site
of infection by this pathogen.
from clinical samples of patients in treatment in Hospital Universitário de Cuiabá – MT. It consists of a retrospective descriptive study. The bacteria were isolated in appropriate culture media. The identification and antimicrobial susceptibility testing were performed by biochemical tests and Kirby Bauer qualitative method, and Etest quantitative one. From 184 tested samples, 85.3% showed multidrug resistance, especially to cephalosporins (3rd and 4th generation), aminoglycosides and carbapenems. However, 100% of the strains were susceptible to polymyxin B. It was observed that the intensive care unit was the most affected by A. baumannii, and tracheal aspirate was the most prevalent site
of infection by this pathogen.
Keywords
Acinetobacter baumannii, antimicrobials, multidrug-resistant
Full Text:
PDF (Português (Brasil))DOI: http://dx.doi.org/10.14450/2318-9312.v25.e4.a2013.pp178-181
Refbacks
- There are currently no refbacks.
Copyright (c) 2014 Infarma - Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Infarma - Ciências Farmacêuticas
ISSN - 2318-9312 (Versão eletrônica)
ISSN - 0104-0219 (Versão impressa)
Conselho Federal de Farmácia - CFF
SHIS QI 15 Lote "L" - Lago Sul - Brasília - DF
CEP: 71635-615 - Fone: (61)3878-8751
e-mail:infarma@cff.org.br
Diretoria
Walter da Silva Jorge João, Presidente do Conselho Federal de Farmácia
Lenira da Silva Costa, Vice-Presidente do Conselho Federal de Farmácia
João Samuel de Morais Meira, Tesoureiro do Conselho Federal de Farmácia
Luiz Gustavo de Freitas Pires, Secretário-Geral do Conselho Federal de Farmácia